Tag | Content |
---|
EnhancerAtlas ID | HS165-00268 |
Organism | Homo sapiens |
Tissue/cell | Ramos |
Coordinate | chr1:28452840-28454800 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Esrra | MA0592.2 | chr1:28452877-28452888 | CTCAAGGTCAT | + | 6.02 | Esrrg | MA0643.1 | chr1:28452878-28452888 | TCAAGGTCAT | + | 6.02 | SPI1 | MA0080.4 | chr1:28454307-28454321 | AGAAAGGGGAAGTG | + | 6.22 | SPIB | MA0081.2 | chr1:28454309-28454321 | AAAGGGGAAGTG | + | 6.07 | STAT1 | MA0137.3 | chr1:28454538-28454549 | TTTCTGGGAAA | + | 6.02 | STAT3 | MA0144.2 | chr1:28454538-28454549 | TTTCTGGGAAA | + | 6.32 | Stat4 | MA0518.1 | chr1:28454538-28454552 | TTTCTGGGAAATCA | + | 6.2 | TBX2 | MA0688.1 | chr1:28453070-28453081 | TTTCACACCTC | - | 6.14 | ZNF263 | MA0528.1 | chr1:28453024-28453045 | TTTCCCCCTCCTTCCTCCACA | - | 6.26 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_09203 | chr1:28451257-28456311 | CD14 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr1 | 28453663 | 28453991 | chr1 | 28454216 | 28454379 | chr1 | 28453901 | 28454800 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I028125 | chr1 | 28451912 | 28456370 |
|
Enhancer Sequence | CAATAGCTAC CTTATGTACT ATAGCTCATT GAATCTTCTC AAGGTCATGC AAGGCAAGTG 60 GTATTACCCC ATTTGCAGAT TGGAACACTG AGGCTCAGAG TGGTCAAGGC ATTGTTTTGC 120 TCAAGTTTCC ACAACCAAGA AGTAGCTGAC CTGGGATTTA AACCTGGGAA GGTGACATTG 180 AATATTTCCC CCTCCTTCCT CCACATTATT CTGCCTACCC CGGAGACGAG TTTCACACCT 240 CCTTTCCTCA GCCTCTCTTG GTCTTGGGTG AATTCATCCT CTTTCCAAGA CATGTTTTGC 300 CAGTCAAGCC CTTGAAGGTC CTTTCAGGTC CATGAAGCTG ATTGCTTTTA AATGTAGGTC 360 CCTTAGGAGA TGACTTCATC TCAATCTTCC AATCCTCTCA TTTTATATAT AGAGAGAAAC 420 TTAGTCTCAC CATCTTTTAT AATTTTCTAC AGAAATTAAA GTTTCTCTTC TGAATTATAA 480 AGTCATGATA AAACGTATCT TCCAAAGGAC GTAGGAATTG ATCTGAAATT TCATCAAAAG 540 TTTATCTCAA ACGTTAAATC ATGATCATTC TGGGGCACTT CCACATTCCA GATCTACAAG 600 TGTCAAAGCT AAGGGAACTG AACAAAATAT ATAGAACTGT ATATCTCAGA AAAGAGAAGT 660 AGCAGCAGTT GACAGGAAGA GCAACATCCT CAATTTTCAA GATATTTACA AAGTTTGTGT 720 GTGTTTTTCT CTTCCTAAGT TCCCTCTTCA AAGAAAATTA TTCCTCCCCA GTTCCAATAA 780 ACTTTTGCTG ACCAGCACAA CCTGTCCACC TTTGCTATTA AAGGGACAAA AAGTAAGTCA 840 GCTATGAGGC ACCTTATATA TTAGTAAAAA CTAAAAATAA TTATAACAGT CAGTGCTGGC 900 AAGGATATGA CAAAACTAGT ATTTACATAA TTTGCTGGTG GTGGTGTAAC TGTCACAACC 960 CTTCAAAAAG AACTTTGGCA ATATATTTCA CCGGGTGGTA ATTCCTTTCC CAGAACTTTA 1020 TTATAACTAA ATTATAATAA AGGGGAAACA AAGTAGCAAA AACCTGGAAA TGACTTGCAT 1080 GTCACGTGTT TTGAGCACTT ACTTTGTAGC AGGTTCTATG TTATACACTC AACACAAATA 1140 ATCTCATTTA ATCCTCAAAA CAATTCTAGG AGGGATATGC TATTTTACTC CTTGTATTCT 1200 GAATGGGGAA ACTGGGACTA CAAGGAATAA AGTAATTTTC CCATGGCTCA ACAGCTGTAG 1260 GGCAAGGGAG GGTTTAAATC ATTGAGGAAC AATGAAGATA CAGAATTCTT CTTCCTTCTA 1320 CAGTAGTGTA TGGAGAAGGG GCATGGATGG CCACTTCTCA AGCCTCTACA ATGTGCTAGT 1380 TACTGTAGAT TGGTTGTCTC ATTAAAGCCT CTCATCTTCA AGATAGGAGA TCAATAGACT 1440 CTTTGACAAG TGTGGAAACT GATACTAAGA AAGGGGAAGT GGTCAACTCA GTCAGACAAC 1500 AAGTGATCAC TGTCCCAGAA TTCTAGCCCA GCATGTCTGA TTCTAGAGTC CATGCTCCTT 1560 CCTCAGGCTG TCTCTTTAAG AAAGACTCAA AATATAGTAA CTGAAGTCAA TTCAGGCATG 1620 GGGAATGTTG GGCTGGTGGA GATGGGGAGG ATGTTTGACC GCTGAGCCTA GAGGACACTG 1680 ACCTATCTCC AGAGGCACTT TCTGGGAAAT CAGACAGCCC TAGGTTTGGG ATCCAAGGAG 1740 GAGTGGGAAC ATGGTATAGC CTTAGCAGGT CTTTAACCGA GGCAGCTAAG AGGCAGGTAA 1800 TATGCAAAGT CTGAGGCTAT GTTCAGTCAC AACTGGAGAA CTAAATAGAA AAATTGAGGC 1860 AGAATCTCAG TCAAGGACCA TAGCAGCATG GGAGAAGAAG AAGACGGCAG CATTGTGATT 1920 TGTGGGTTTC CAGAAGTACC CTCCAATACT CCATGGCCTT 1960
|